发明申请
- 专利标题： MAPK/ERK KINASE INHIBITORS
- 专利标题（中）： MAPK / ERK激酶抑制剂
-
申请号： US12267353申请日： 2008-11-07
-
公开(公告)号： US20090124595A1公开(公告)日： 2009-05-14
- 发明人: MarK Adams , Qing Dong , Toufike Kanouni , Stephen W. Kaldor , Nicholas Scorah , Michael B. Wallace
- 申请人： MarK Adams , Qing Dong , Toufike Kanouni , Stephen W. Kaldor , Nicholas Scorah , Michael B. Wallace
- 申请人地址： JP OSAKA
- 专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址： JP OSAKA
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437 ; A61K31/4375 ; C07D513/04 ; C07D498/04 ; A61P35/04 ; C12N9/99
摘要：
Compounds of the following formula are provided for use with MEK: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
公开/授权文献
- US08022057B2 MAPK/ERK kinase inhibitors 公开/授权日：2011-09-20
信息查询
